Akoya Biosciences Inc (AKYA)
3.80
-0.02
(-0.52%)
USD |
NASDAQ |
Apr 26, 16:00
3.81
+0.01
(+0.26%)
After-Hours: 20:00
Akoya Biosciences Gross Profit Margin (Quarterly): 62.75% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 62.75% |
| September 30, 2023 | 60.58% |
| June 30, 2023 | 51.51% |
| March 31, 2023 | 57.42% |
| December 31, 2022 | 56.77% |
| September 30, 2022 | 57.86% |
| June 30, 2022 | 57.79% |
| March 31, 2022 | 59.76% |
| Date | Value |
|---|---|
| December 31, 2021 | 63.29% |
| September 30, 2021 | 62.73% |
| June 30, 2021 | 62.23% |
| March 31, 2021 | 60.64% |
| December 31, 2020 | 61.26% |
| September 30, 2020 | 60.62% |
| June 30, 2020 | 61.57% |
| March 31, 2020 | 60.76% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
51.51%
Minimum
Jun 2023
63.29%
Maximum
Dec 2021
59.85%
Average
60.63%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 50.36% |
| Azenta Inc | 39.86% |
| Harvard Bioscience Inc | 57.99% |
| Bionano Genomics Inc | 22.74% |
| Singular Genomics Systems Inc | -42.28% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -109.8% |
| Return on Assets | -36.11% |
| Return on Invested Capital | -51.25% |
| Profit Margin (Quarterly) | -40.78% |
| Operating Margin (Quarterly) | -33.31% |
| Return on Net Operating Assets | -71.10% |